About Us
Technology
- Conditionally Active Biologics^™ (CAB)
- Comprehensive Integrated Antibody Optimization (CIAO!™)
Strategic Relationships
CAB Portfolio
News
Contact
Appendix
Search

Site Map

About Us
Technology
- Conditionally Active Biologics^™ (CAB)
- Comprehensive Integrated Antibody Optimization (CIAO!™)
Strategic Relationships
CAB Portfolio
News
Contact
Appendix
Search

BioAtla^® is a leading San Diego-based biopharmaceutical company developing safer and more effective drugs for cancer. Its Conditionally Active Biologics^™ (CAB) platform exploits the unique microenvironment of diseased tissue to more effectively target cancer.

BioAtla^®

Technology
CAB Portfolio

Company

About
Team
Careers
News

Legal

Privacy Policy
Site Map
Expanded Access

Get in Touch

Contact
Corporate Headquarters

+1 858-558-0708

Follow Us

LinkedIn

© 2020 BioAtla^® Inc. All rights reserved.